Patrícia Severino

2.5k citations
74 papers · 1.9k indexed · h-index 25

Patrícia Severino

70 papers receiving 1.8k citations

Peers

Patrícia Severino
Comparison fields: 5 of 134
  • Molecular Medicine 123
  • Cancer Research 320
  • Oncology 495
  • Endocrinology 75
  • Inorganic Chemistry 178
Replace Yanming Li with:
Yanming Li China
Zhijie Zhang China
Shirin Eyvazi Iran
Meixiao Zhan China
Ann H. Cory United States
Saugata Hazra India
Jeng‐Fan Lo Taiwan
Weimin Fan China
Johan van Meerloo Netherlands
Patrícia Severino relative to Yanming Li China Yanming Li's profile →
Citations per field
00.5×6.6×
Yanming Li · 1×
Citations per year

Countries citing papers authored by Patrícia Severino

Since Specialization
Citations

This map shows the geographic impact of Patrícia Severino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrícia Severino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrícia Severino more than expected).

Fields of papers citing papers by Patrícia Severino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrícia Severino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrícia Severino. The network helps show where Patrícia Severino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrícia Severino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrícia Severino Line = papers co-authored together Patrícia Severino links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20251
4 202116
5
Natural Products as Treatment against Cancer: A Historical and Current Vision
201943
6 201919
7 20167
8 201420
9 201432
10 201436
11 201312
12 201365
13 201276
14 201114
15 201112
16 201015
17 200844
18 200844
19 200227
20 200264

About Patrícia Severino

Patrícia Severino is a scholar working on Molecular Medicine, Endocrinology and Cancer Research, having authored 74 papers that have together received 1.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Metal complexes synthesis and properties (10 papers), Cancer-related molecular mechanisms research (9 papers), Antibiotic Resistance in Bacteria (9 papers), RNA modifications and cancer (7 papers), DNA and Nucleic Acid Chemistry (6 papers), Gene expression and cancer classification (6 papers) and Immune Response and Inflammation (6 papers). The work is most often cited by research in Molecular Medicine (123 citations), Cancer Research (320 citations) and Oncology (495 citations). Patrícia Severino has collaborated with scholars based in Brazil, United States and Australia. Frequent co-authors include Hernán Terenzi, Renato Puga, Ademir Neves, Cristina Bonorino, Ricardo Weinlich, Dyeison Antonow, Christian Viezzer, Julia C. Fontoura, Rosane Angélica Ligabue and Fábio Daumas Nunes. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026